Hypertension:运动量与老年高血压人群死亡率较低有关

2014-05-19 cath 编译 医学论坛网

美国一项研究表明,运动量与老年高血压人群死亡率较低具有相关性。相关论文5月12日在线发表于《高血压》(HYPERTENSION)杂志。 该研究共纳入2153例年龄≥70岁的男性高血压受试者,对其进行常规运动耐力测试。在代谢当量中评估其峰值运动量。校正年龄后,基于MET峰值确定其健康类别,极低、低、中和高健康水平受试者的MET分别为2.0 —4.0、4.1—6.0、6.1 —8.0和>8.0

美国一项研究表明,运动量与老年高血压人群死亡率较低具有相关性。相关论文5月12日在线发表于《高血压》(HYPERTENSION)杂志。

该研究共纳入2153例年龄≥70岁的男性高血压受试者,对其进行常规运动耐力测试。在代谢当量中评估其峰值运动量。校正年龄后,基于MET峰值确定其健康类别,极低、低、中和高健康水平受试者的MET分别为2.0 —4.0、4.1—6.0、6.1 —8.0和>8.0。校正年龄、体质指数(BMI)、种族、心血管疾病、心血管药物和危险因素后,用Cox比例风险模型计算结果。在平均随访的9.0±5.5年间,定量分析受试者的全因死亡率。

结果显示,随访期间1039例受试者死亡(死亡51.2/1000 人-年)。运动量每增加1 MET,死亡风险降低11%[危险比(HR)0.89]。与那些≤4.0 MET人群相比,低、中和高健康水平受试者死亡风险风别降低18%、36%和48%,HR分别为0.82、0.64和0.52。


原始出处:

Faselis C1, Doumas M, Pittaras A, Narayan P, Myers J, Tsimploulis A, Kokkinos P.Exercise Capacity and All-Cause Mortality in Male Veterans With Hypertension Aged >=70 Years.Hypertension. 2014 May 12. [Epub ahead of print]

       

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2038490, encodeId=5dfc20384901a, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 03 05:44:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059215, encodeId=84102059215b3, content=<a href='/topic/show?id=739f94235ce' target=_blank style='color:#2F92EE;'>#运动量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94235, encryptionId=739f94235ce, topicName=运动量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Tue Mar 31 14:44:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725608, encodeId=d04a1e256080d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Oct 01 17:44:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822338, encodeId=2d1718223380c, content=<a href='/topic/show?id=c4fa1026584a' target=_blank style='color:#2F92EE;'>#高血压人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102658, encryptionId=c4fa1026584a, topicName=高血压人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Sep 18 02:44:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478895, encodeId=468414e889525, content=<a href='/topic/show?id=5de08024597' target=_blank style='color:#2F92EE;'>#老年高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80245, encryptionId=5de08024597, topicName=老年高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87307462084, createdName=124985dbm08(暂无昵称), createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501044, encodeId=d7ee1501044e4, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2038490, encodeId=5dfc20384901a, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 03 05:44:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059215, encodeId=84102059215b3, content=<a href='/topic/show?id=739f94235ce' target=_blank style='color:#2F92EE;'>#运动量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94235, encryptionId=739f94235ce, topicName=运动量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Tue Mar 31 14:44:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725608, encodeId=d04a1e256080d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Oct 01 17:44:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822338, encodeId=2d1718223380c, content=<a href='/topic/show?id=c4fa1026584a' target=_blank style='color:#2F92EE;'>#高血压人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102658, encryptionId=c4fa1026584a, topicName=高血压人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Sep 18 02:44:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478895, encodeId=468414e889525, content=<a href='/topic/show?id=5de08024597' target=_blank style='color:#2F92EE;'>#老年高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80245, encryptionId=5de08024597, topicName=老年高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87307462084, createdName=124985dbm08(暂无昵称), createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501044, encodeId=d7ee1501044e4, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
    2015-03-31 xuyu
  3. [GetPortalCommentsPageByObjectIdResponse(id=2038490, encodeId=5dfc20384901a, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 03 05:44:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059215, encodeId=84102059215b3, content=<a href='/topic/show?id=739f94235ce' target=_blank style='color:#2F92EE;'>#运动量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94235, encryptionId=739f94235ce, topicName=运动量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Tue Mar 31 14:44:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725608, encodeId=d04a1e256080d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Oct 01 17:44:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822338, encodeId=2d1718223380c, content=<a href='/topic/show?id=c4fa1026584a' target=_blank style='color:#2F92EE;'>#高血压人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102658, encryptionId=c4fa1026584a, topicName=高血压人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Sep 18 02:44:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478895, encodeId=468414e889525, content=<a href='/topic/show?id=5de08024597' target=_blank style='color:#2F92EE;'>#老年高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80245, encryptionId=5de08024597, topicName=老年高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87307462084, createdName=124985dbm08(暂无昵称), createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501044, encodeId=d7ee1501044e4, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
    2014-10-01 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=2038490, encodeId=5dfc20384901a, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 03 05:44:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059215, encodeId=84102059215b3, content=<a href='/topic/show?id=739f94235ce' target=_blank style='color:#2F92EE;'>#运动量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94235, encryptionId=739f94235ce, topicName=运动量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Tue Mar 31 14:44:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725608, encodeId=d04a1e256080d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Oct 01 17:44:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822338, encodeId=2d1718223380c, content=<a href='/topic/show?id=c4fa1026584a' target=_blank style='color:#2F92EE;'>#高血压人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102658, encryptionId=c4fa1026584a, topicName=高血压人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Sep 18 02:44:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478895, encodeId=468414e889525, content=<a href='/topic/show?id=5de08024597' target=_blank style='color:#2F92EE;'>#老年高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80245, encryptionId=5de08024597, topicName=老年高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87307462084, createdName=124985dbm08(暂无昵称), createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501044, encodeId=d7ee1501044e4, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2038490, encodeId=5dfc20384901a, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 03 05:44:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059215, encodeId=84102059215b3, content=<a href='/topic/show?id=739f94235ce' target=_blank style='color:#2F92EE;'>#运动量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94235, encryptionId=739f94235ce, topicName=运动量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Tue Mar 31 14:44:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725608, encodeId=d04a1e256080d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Oct 01 17:44:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822338, encodeId=2d1718223380c, content=<a href='/topic/show?id=c4fa1026584a' target=_blank style='color:#2F92EE;'>#高血压人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102658, encryptionId=c4fa1026584a, topicName=高血压人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Sep 18 02:44:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478895, encodeId=468414e889525, content=<a href='/topic/show?id=5de08024597' target=_blank style='color:#2F92EE;'>#老年高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80245, encryptionId=5de08024597, topicName=老年高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87307462084, createdName=124985dbm08(暂无昵称), createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501044, encodeId=d7ee1501044e4, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2038490, encodeId=5dfc20384901a, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 03 05:44:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059215, encodeId=84102059215b3, content=<a href='/topic/show?id=739f94235ce' target=_blank style='color:#2F92EE;'>#运动量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94235, encryptionId=739f94235ce, topicName=运动量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Tue Mar 31 14:44:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725608, encodeId=d04a1e256080d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Oct 01 17:44:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822338, encodeId=2d1718223380c, content=<a href='/topic/show?id=c4fa1026584a' target=_blank style='color:#2F92EE;'>#高血压人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102658, encryptionId=c4fa1026584a, topicName=高血压人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Sep 18 02:44:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478895, encodeId=468414e889525, content=<a href='/topic/show?id=5de08024597' target=_blank style='color:#2F92EE;'>#老年高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80245, encryptionId=5de08024597, topicName=老年高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87307462084, createdName=124985dbm08(暂无昵称), createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501044, encodeId=d7ee1501044e4, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Wed May 21 02:44:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]

相关资讯

JAMA:有氧训练可改善超重或肥胖儿童的健康状况

为了检测不同有氧运动量对胰岛素抵抗,肥胖,内脏脂肪,超重健康因素,欠缺运动儿童健康的影响,以及性别和种族在其中的起到了怎样的作用,美国乔治亚州医学院公共健康与预防中心Catherine L. Davis博士等人的进行了深入研究,他们发现经过13周的20或40 min/d 的有氧训练可改善欠缺运动的超重或肥胖儿童的肥胖或内脏肥胖健康状况,并证实其胰岛素抵抗受益有运动量反应性。相关论文发表于国际权威杂